Correlation Between Lantern Pharma and Coeptis Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lantern Pharma and Coeptis Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lantern Pharma and Coeptis Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lantern Pharma and Coeptis Therapeutics, you can compare the effects of market volatilities on Lantern Pharma and Coeptis Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lantern Pharma with a short position of Coeptis Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lantern Pharma and Coeptis Therapeutics.

Diversification Opportunities for Lantern Pharma and Coeptis Therapeutics

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Lantern and Coeptis is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Lantern Pharma and Coeptis Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coeptis Therapeutics and Lantern Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lantern Pharma are associated (or correlated) with Coeptis Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coeptis Therapeutics has no effect on the direction of Lantern Pharma i.e., Lantern Pharma and Coeptis Therapeutics go up and down completely randomly.

Pair Corralation between Lantern Pharma and Coeptis Therapeutics

Given the investment horizon of 90 days Lantern Pharma is expected to generate 1.13 times more return on investment than Coeptis Therapeutics. However, Lantern Pharma is 1.13 times more volatile than Coeptis Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Coeptis Therapeutics is currently generating about -0.09 per unit of risk. If you would invest  392.00  in Lantern Pharma on September 4, 2024 and sell it today you would lose (76.00) from holding Lantern Pharma or give up 19.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Lantern Pharma  vs.  Coeptis Therapeutics

 Performance 
       Timeline  
Lantern Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lantern Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Coeptis Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Coeptis Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable technical and fundamental indicators, Coeptis Therapeutics is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

Lantern Pharma and Coeptis Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lantern Pharma and Coeptis Therapeutics

The main advantage of trading using opposite Lantern Pharma and Coeptis Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lantern Pharma position performs unexpectedly, Coeptis Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coeptis Therapeutics will offset losses from the drop in Coeptis Therapeutics' long position.
The idea behind Lantern Pharma and Coeptis Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm